MED (Medifast) Cyclically Adjusted Revenue per Share: $80.99 (As of Mar. 2026)


MED Medifast Inc MED
67 GF Score
Price $10.71
GF Value $8.64
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medifast Cyclically Adjusted Revenue per Share?

Medifast MED +0.33% 67 Cyclically Adjusted Revenue per Share is $80.99 as of Mar. 2026. GuruFocus rates MED with a GF Score™ of 67/100 and a GF Value™ of $8.64 (Modestly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medifast's adjusted revenue per share for the three months ended in Mar. 2026 was $6.909. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $80.99 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Medifast's average Cyclically Adjusted Revenue Growth Rate was 3.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 16.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 19.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medifast was 35.10% per year. The lowest was 7.80% per year. And the median was 19.80% per year.

As of today (2026-07-09), Medifast's current stock price is $10.705. Medifast's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $80.99. Medifast's Cyclically Adjusted PS Ratio of today is 0.13.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medifast was 10.96. The lowest was 0.12. And the median was 2.36.


Medifast  (NYSE:MED) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medifast's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=10.705/80.99
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medifast was 10.96. The lowest was 0.12. And the median was 2.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medifast Cyclically Adjusted Revenue per Share Related Terms


Medifast Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medifast's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medifast Cyclically Adjusted Revenue per Share Chart

Medifast Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.07 63.53 72.48 77.13 79.63

Medifast Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 78.39 79.22 79.84 79.63 80.99

MED vs RGS, EVTK, DROR: Cyclically Adjusted Revenue per Share Comparison

For the Personal Services subindustry, Medifast's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast Cyclically Adjusted PS Ratio vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medifast's Cyclically Adjusted PS Ratio falls into.


MED
67GF Score
Medifast Inc MED
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medifast Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medifast's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=6.909/330.2130*330.2130
=6.909

Current CPI (Mar. 2026) = 330.2130.

Medifast Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 5.987 241.018 8.203
201609 5.740 241.428 7.851
201612 5.200 241.432 7.112
201703 5.881 243.801 7.965
201706 6.281 244.955 8.467
201709 6.383 246.819 8.540
201712 6.413 246.524 8.590
201803 8.122 249.554 10.747
201806 9.637 251.989 12.629
201809 11.510 252.439 15.056
201812 12.174 251.233 16.001
201903 13.552 254.202 17.604
201906 15.314 256.143 19.742
201909 15.753 256.759 20.260
201912 14.284 256.974 18.355
202003 15.093 258.115 19.309
202006 18.611 257.797 23.839
202009 22.895 260.280 29.047
202012 22.299 260.474 28.269
202103 28.673 264.877 35.746
202106 33.242 271.696 40.402
202109 35.078 274.310 42.227
202112 32.205 278.802 38.144
202203 35.882 287.504 41.212
202206 39.644 296.311 44.180
202209 35.356 296.808 39.335
202212 30.667 296.797 34.120
202303 32.020 301.836 35.030
202306 27.131 305.109 29.363
202309 21.574 307.789 23.146
202312 17.510 306.746 18.850
202403 15.946 312.332 16.859
202406 15.412 314.175 16.199
202409 12.776 315.301 13.380
202412 10.843 315.605 11.345
202503 10.571 319.799 10.915
202506 9.544 322.561 9.770
202509 8.135 324.800 8.271
202512 6.831 324.054 6.961
202603 6.909 330.213 6.909

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $80.99 mean?
Medifast (MED) has a Cyclically Adjusted Revenue per Share of $80.99 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medifast and its competitors.
Is Medifast's Cyclically Adjusted Revenue per Share too high?
Medifast's current Cyclically Adjusted Revenue per Share is $80.99. Overall, Medifast has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's Cyclically Adjusted Revenue per Share compare to RGS and EVTK?
Medifast's Cyclically Adjusted Revenue per Share of $80.99 can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Personal Services company?
A good Cyclically Adjusted Revenue per Share depends on the Personal Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medifast and its competitors. Medifast's current Cyclically Adjusted Revenue per Share is $80.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (MED) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.64, compared to a current price of $10.71 — trading 23.9% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $80.99. Medifast's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medifast (MED), the current Cyclically Adjusted Revenue per Share is $80.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medifast (MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of $10.71 is trading 23.9% above its estimated GF Value™ of $8.64. GuruFocus considers Medifast to be Modestly Overvalued.

Key valuation signals for MED:

  • Cyclically Adjusted Revenue per Share: $80.99
  • GF Value™: $8.64 vs. price of $10.71 (23.9% above fair value)
  • GF Score™: 67/100 with 2 warning signs

No single metric tells the full story. See the MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medifast Business Description

Other Exchanges 0K05:UKMDF:Germany
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
67GF Score

Get the complete analysis for MED

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.71
Price
$8.64
GF Value